Mary E. Willy

2.7k total citations
28 papers, 2.1k citations indexed

About

Mary E. Willy is a scholar working on Public Health, Environmental and Occupational Health, Pharmacology and Epidemiology. According to data from OpenAlex, Mary E. Willy has authored 28 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Public Health, Environmental and Occupational Health, 7 papers in Pharmacology and 6 papers in Epidemiology. Recurrent topics in Mary E. Willy's work include Pharmacovigilance and Adverse Drug Reactions (5 papers), Poisoning and overdose treatments (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Mary E. Willy is often cited by papers focused on Pharmacovigilance and Adverse Drug Reactions (5 papers), Poisoning and overdose treatments (4 papers) and Drug-Induced Hepatotoxicity and Protection (4 papers). Mary E. Willy collaborates with scholars based in United States, Cuba and India. Mary E. Willy's co-authors include Stephen J. Pont, William O. Cooper, Wayne A. Ray, Parivash Nourjah, Syed Rizwanuddin Ahmad, Claudia B. Karwoski, Judy A. Staffa, Richard Platt, Marsha A. Raebel and James M. Livingston and has published in prestigious journals such as Annals of Internal Medicine, Journal of Clinical Microbiology and American Journal of Obstetrics and Gynecology.

In The Last Decade

Mary E. Willy

28 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mary E. Willy United States 18 827 380 347 346 292 28 2.1k
Doreen Matsui Canada 29 1.0k 1.3× 98 0.3× 1.0k 2.9× 257 0.7× 58 0.2× 87 3.0k
Vanessa Pauly France 28 445 0.5× 106 0.3× 199 0.6× 492 1.4× 110 0.4× 135 2.7k
Dianne L. Kennedy United States 21 404 0.5× 140 0.4× 255 0.7× 181 0.5× 29 0.1× 42 1.7k
J Weil United Kingdom 25 181 0.2× 90 0.2× 621 1.8× 683 2.0× 86 0.3× 47 3.2k
Ami Claxton United States 16 257 0.3× 106 0.3× 377 1.1× 513 1.5× 80 0.3× 28 3.2k
Cho Lee Wong Hong Kong 23 309 0.4× 344 0.9× 323 0.9× 120 0.3× 34 0.1× 117 1.6k
Samuel M. Lesko United States 28 442 0.5× 371 1.0× 393 1.1× 286 0.8× 13 0.0× 46 2.7k
Ari Shamiss Israel 28 572 0.7× 204 0.5× 332 1.0× 412 1.2× 131 0.4× 61 2.5k
David Rigau Spain 23 638 0.8× 160 0.4× 85 0.2× 834 2.4× 92 0.3× 66 4.0k
Marc Levine Canada 24 220 0.3× 133 0.3× 398 1.1× 227 0.7× 9 0.0× 61 1.7k

Countries citing papers authored by Mary E. Willy

Since Specialization
Citations

This map shows the geographic impact of Mary E. Willy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Willy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Willy more than expected).

Fields of papers citing papers by Mary E. Willy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Willy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Willy. The network helps show where Mary E. Willy may publish in the future.

Co-authorship network of co-authors of Mary E. Willy

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Willy. A scholar is included among the top collaborators of Mary E. Willy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Willy. Mary E. Willy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Henderson, David K., Mary E. Willy, J Schmitt, et al.. (2020). Risk for Occupational Transmission of Human Immunodeficiency Virus Type 1 (HIV-1) Associated with Clinical Exposures. Annals of Internal Medicine. 1 indexed citations
2.
Hampp, Christian, et al.. (2015). Patient understanding of drug risks: an evaluation of medication guide assessments. Pharmacoepidemiology and Drug Safety. 24(5). 518–525. 17 indexed citations
3.
Willy, Mary E., David J. Graham, Judith A. Racoosin, et al.. (2014). Candidate Metrics for Evaluating the Impact of Prescriber Education on the Safe Use of Extended-Release/Long-Acting (ER/LA) Opioid Analgesics. Pain Medicine. 15(9). 1558–1568. 11 indexed citations
4.
Manthripragada, Angelika D., Esther H. Zhou, Daniel S. Budnitz, Maribeth C. Lovegrove, & Mary E. Willy. (2011). Characterization of acetaminophen overdose‐related emergency department visits and hospitalizations in the United States. Pharmacoepidemiology and Drug Safety. 20(8). 819–826. 62 indexed citations
5.
Lo, Joan C., Felice O’Ryan, Nancy P. Gordon, et al.. (2009). Prevalence of Osteonecrosis of the Jaw in Patients With Oral Bisphosphonate Exposure. Journal of Oral and Maxillofacial Surgery. 68(2). 243–253. 361 indexed citations
6.
Willy, Mary E., Deloris E. Koziol, Thomas A. Fleisher, et al.. (2009). Measles Immunity in a Population of Healthcare Workers. Infection Control and Hospital Epidemiology. 15(1). 12–17. 3 indexed citations
7.
Andrade, Susan E., Heather McPhillips, David J. Loren, et al.. (2009). Antidepressant medication use and risk of persistent pulmonary hypertension of the newborn. Pharmacoepidemiology and Drug Safety. 18(3). 246–252. 135 indexed citations
8.
Weaver, Joyce, Mary E. Willy, & Mark Avigan. (2008). Informatic Tools and Approaches in Postmarketing Pharmacovigilance Used by FDA. The AAPS Journal. 10(1). 35–41. 35 indexed citations
9.
Willy, Mary E., Judith P. Kelly, Parivash Nourjah, et al.. (2008). Emergency department visits attributed to selected analgesics, United States, 2004–2005. Pharmacoepidemiology and Drug Safety. 18(3). 188–195. 16 indexed citations
10.
Kortepeter, Cindy, et al.. (2008). Drug-risk communication to pharmacists: Assessing the impact of risk-minimization strategies on the practice of pharmacy. Journal of the American Pharmacists Association. 48(4). 494–500. 12 indexed citations
11.
Andrade, Susan E., Marsha A. Raebel, Jeffrey S. Brown, et al.. (2007). Use of antidepressant medications during pregnancy: a multisite study. American Journal of Obstetrics and Gynecology. 198(2). 194.e1–194.e5. 337 indexed citations
12.
Cooper, William O., Mary E. Willy, Stephen J. Pont, & Wayne A. Ray. (2007). Increasing use of antidepressants in pregnancy. American Journal of Obstetrics and Gynecology. 196(6). 544.e1–544.e5. 368 indexed citations
13.
Mosholder, Andrew D. & Mary E. Willy. (2006). Suicidal Adverse Events in Pediatric Randomized, Controlled Clinical Trials of Antidepressant Drugs Are Associated with Active Drug Treatment: AMeta-Analysis. Journal of Child and Adolescent Psychopharmacology. 16(1-2). 25–32. 45 indexed citations
14.
Nourjah, Parivash, Syed Rizwanuddin Ahmad, Claudia B. Karwoski, & Mary E. Willy. (2005). Estimates of acetaminophen (paracetomal)‐associated overdoses in the United States. Pharmacoepidemiology and Drug Safety. 15(6). 398–405. 231 indexed citations
15.
Willy, Mary E. & Zili Li. (2003). What is prescription labeling communicating to doctors about hepatotoxic drugs? A study of FDA approved product labeling. Pharmacoepidemiology and Drug Safety. 13(4). 201–206. 17 indexed citations
16.
Willy, Mary E., et al.. (2002). A Study of Compliance With FDA Recommendations for Pemoline (Cylert®). Journal of the American Academy of Child & Adolescent Psychiatry. 41(7). 785–790. 24 indexed citations
17.
Willy, Mary E., Donald R. Hoover, Neal A. Halsey, et al.. (1998). RELATIONSHIP BETWEEN UNSUPPLEMENTED VITAMIN A SERUM CONCENTRATIONS AND MEASLES VACCINE RESPONSE IN JAMAICAN CHILDREN. The Pediatric Infectious Disease Journal. 17(6). 526–528. 1 indexed citations
18.
Singh-Naz, Nalini, et al.. (1990). Outbreak of parainfluenza virus type 3 in a neonatal nursery. The Pediatric Infectious Disease Journal. 9(1). 31–32. 33 indexed citations
19.
Willy, Mary E., et al.. (1990). Adverse Exposures and Universal Precautions Practices among a Group of Highly Exposed Health Professionals. Infection Control and Hospital Epidemiology. 11(7). 351–356. 30 indexed citations
20.
Weems, J. John, et al.. (1987). Candida parapsilosis fungemia associated with parenteral nutrition and contaminated blood pressure transducers. Journal of Clinical Microbiology. 25(6). 1029–1032. 146 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Doreen Matsui Breakdown of academic impact, for papers by Vanessa Pauly Breakdown of academic impact, for papers by Dianne L. Kennedy Breakdown of academic impact, for papers by J Weil Breakdown of academic impact, for papers by Ami Claxton Breakdown of academic impact, for papers by Cho Lee Wong Breakdown of academic impact, for papers by Samuel M. Lesko Breakdown of academic impact, for papers by Ari Shamiss Breakdown of academic impact, for papers by David Rigau Breakdown of academic impact, for papers by Marc Levine
Rankless by CCL
2026